ADVFN - Advanced Financial Network.
HOME» NYSE » N » NVS Stock Price » NVS Stock News

Novartis Share News

 Novartis Ag Basel Stock Price
NVS Stock Price
 Novartis Ag Basel Stock Chart
NVS Stock Chart
 Novartis Ag Basel Stock News
NVS Stock News
 Novartis Ag Basel Company Information
NVS Company Information
 Novartis Ag Basel Stock Trades
NVS Stock Trades

Novartis Plans CHF500 Million New Manufacturing Facility

ZURICH -(Dow Jones)- Swiss pharmaceutical company Novartis AG (NVS) said Monday it is planning to invest over 500 million Swiss francs ($550 million) building a new manufacturing facility in Switzerland. MAIN FACTS: -The company said the investment underlines the long-term strategy of Novartis to establish a worldwide manufacturing network of technology centers. -The new production site in Stein, Switzerland, is expected to be fully operational by end of 2016. -"This investment is further strengthening the importance of Stein as Manufacturing Center of Excellence for sterile and solid dosage forms and will play a key role in our global production network," said Joseph Jimenez, CEO of Novartis. "It also strengthens our presence in Switzerland, which remains a center of key importance for Novartis." -The Stein site in Canton Aargau is the largest production facility of the Pharmaceuticals Division. Every year, the approximately 1,400 associates at the site produce over 4.1 billion tablets, capsules, ampoules, prefilled syringes, vials and transdermal therapeutic systems, which are exported to over 150 countries. -The new set-up will allow Novartis to adapt its production capacity more quickly depending on an evolving portfolio and market demand. The center will serve approximately 150 markets globally. -Zurich Bureau, Dow Jones Newswires, +41 43 443 80 47; zurichdjnews@dowjones.com

Stock News for Novartis (NVS)
DateTimeHeadline
02/09/201613:00:00Novartis Reaches Entresto Pay-for-Performance Deals With Cigna...
02/09/201612:57:00Novartis Reaches Entresto Pay-for-Performance Deals With Cigna...
02/03/201611:04:00Investors' Fears Eased as Glaxo Posts Solid Results -- Update
02/03/201608:30:00GlaxoSmithKline Posts $510 Million Net Loss
02/03/201608:23:00GlaxoSmithKline Posts GBP354 Million Net Loss in 4Q
01/28/201616:40:00Amgen Profit Rises 39%; 2016 Outlook Raised
01/27/201616:30:00Radius Health Announces Clinical Collaboration With a Leading...
01/27/201609:57:00Novartis Profit Dives 57% on Eye-Care Woes --2nd Update
01/27/201605:10:00Global Stocks Edge Lower Ahead of U.S. Interest Rate Decision
01/27/201604:44:00Novartis Profit Dives 57% on Eye-Care Woes --2nd Update
01/27/201603:01:00Novartis Net Profit Falls 57% --Update
01/27/201602:50:00Novartis Net Profit Falls 57%
01/27/201602:02:00Novartis 4Q Net Profit Falls 57% as Eye-Care Unit Drags on Results
01/22/201611:53:00CEOs Sanguine on M&A Prospects in Spite of Markets Dive --Update
01/22/201609:06:00Novartis AG 4Q 2015 -- Forecast
01/20/201619:29:00Drug and Diagnostic Companies Issue Joint Declaration on Antibiotics
01/11/201610:10:00Juno Agrees to Acquire AbVitro
12/17/201519:49:00Ligand Pharma to Buy Genetic Engineering Company OMT -- 2nd Update
12/17/201505:10:00Global Stocks Rally After Fed Decision
12/07/201515:53:00U.S. Stocks Fall as Oil Keeps Sliding

Novartis and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad